Storage Conditions and Breast Milk Microbiota Composition
The Effect of Storage Conditions on Microbiota Composition of Breast Milk
1 other identifier
observational
20
1 country
1
Brief Summary
Breast milk is the mainstay of newborn nutrition, providing all the nutrients and vitamins necessary for optimal growth of newborn infants. Beside its nutritional properties, breast milk also contains bioactive factors such as soluble immune factors, antimicrobial proteins, functional fatty acids, hormones, oligosaccharides, stem cells and microbiota. Although fresh breast milk is the optimal source of nutrition for newborn infants, breast milk must be expressed and stored in some conditions. Breast milk was thought to be sterile for many years. This idea has changed with the isolation of live bacteria in the breast milk of healthy mothers in the recent past. Thus, it has been shown that breast milk is not actually a sterile body fluid, but has a microbiota of its own. This study aimed to examine the effect of storage conditions of breast milk at different temperatures on the microbial composition of the breast milk. The prospective experimental study will be conducted under the supervision of Istanbul University, Istanbul Medical Faculty, Department of Pediatrics, Neonatology Department. Informed consent of mothers will be taken. Thirty mililiter (30 mL) breast milk that was obtained from volunteer mothers will be divided into 3 samples, each 10 mL of breast milk will be stored at different temperatures. Ten mililiter will be studied for microbial composition with 16S rRNA amplicon sequencing and bioinformatics analysis immediately, 10 mL will be stored at +4'C for 3 days and will be studied at the end of 3rd day, other 10 mL will be stored at -20'C for 3 months and will be studied at the end of 3rd months. 16S rRNA amplicon sequencing and bioinformatic analysis studies will be performed at Istanbul Medical Faculty Clinical Nutrition and Microbiota Research Laboratory. This present study is planned to be carried out for 24 months between January 2023 and December 2024
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 20, 2022
CompletedFirst Posted
Study publicly available on registry
January 3, 2023
CompletedStudy Start
First participant enrolled
May 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 14, 2024
CompletedMay 19, 2023
May 1, 2023
4 months
December 20, 2022
May 18, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in microbiota composition of breast milk after storage
To evaluate the effects of different storage conditions on microbiota composition of breast milk
24 months
Study Arms (3)
Fresh breast milk
Fresh breast milk obtained from volunteer mothers will be divided into four parts. Fresh breast milk will be studied for microbiota composition immediately within 3 hours.
Breast milk stored at +4'C for 3 days
One part of previously obtained fresh breast milk will be stored at +4'C at refrigerator for 3 days long, then microbiota composition will be studied.
Breast milk stored at -20'C for 3 months
Last part of the same breast milk specimen will be freezed at -20'C for 3 months and microbiota composition of the 3 months frozen milk will be studied.
Eligibility Criteria
Healthy young mothers who had vaginal delivery at least one week ago will be included
You may qualify if:
- Women who had vaginal delivery
- Women who gave delivery at gestational age above 37 weeks
- Women who have a child older than 1 weeks of age
- Mothers with a body mass index between 18.5-25
- Women who gave consent
You may not qualify if:
- Women who had cesarean delivery
- Women who gave premature delivery (\<37 weeks of gestation)
- Women who gave birth within prior 7 days
- Women with premature rupture of membranes
- Women with chorioamnionitis
- Women who had antibiotherapy within last 1 week
- Presence of mastitis
- Presence of maternal co-morbid diseases such as; pregestational diabetes, pregestational hypertension, connective tissue diseases, inflammatory bowel syndrome, solid organ transplantation
- Presence of evidenced congenital infections
- Women who didn't give consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul University Istanbul Medical Faculty
Istanbul, Turkey (Türkiye)
Related Publications (3)
Selma-Royo M, Calvo Lerma J, Cortes-Macias E, Collado MC. Human milk microbiome: From actual knowledge to future perspective. Semin Perinatol. 2021 Oct;45(6):151450. doi: 10.1016/j.semperi.2021.151450. Epub 2021 Jun 16.
PMID: 34274151BACKGROUNDPandya SP, Doshi H, Codipilly CN, Fireizen Y, Potak D, Schanler RJ. Bacterial stability with freezer storage of human milk. J Perinat Med. 2020 Sep 14;49(2):225-228. doi: 10.1515/jpm-2020-0131. Print 2021 Feb 23.
PMID: 32915767BACKGROUNDFernandez L, Ruiz L, Jara J, Orgaz B, Rodriguez JM. Strategies for the Preservation, Restoration and Modulation of the Human Milk Microbiota. Implications for Human Milk Banks and Neonatal Intensive Care Units. Front Microbiol. 2018 Nov 9;9:2676. doi: 10.3389/fmicb.2018.02676. eCollection 2018.
PMID: 30473683RESULT
Biospecimen
Breast milk
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emine Asuman Coban, Professor
Istanbul University
- PRINCIPAL INVESTIGATOR
Elmas Zeynep Ince, Professor
Istanbul University
- PRINCIPAL INVESTIGATOR
Bülent Saka, Professor
Istanbul University
- PRINCIPAL INVESTIGATOR
Leyla Bilgin, Professor
Istanbul University
- PRINCIPAL INVESTIGATOR
Dilek Sever Kaya, Dr Biologist
Istanbul University
- PRINCIPAL INVESTIGATOR
Aslı Berru Arslan, Med Student
Istanbul University
- STUDY DIRECTOR
Beril Yasa, Ass. Prof.
Istanbul University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
December 20, 2022
First Posted
January 3, 2023
Study Start
May 12, 2023
Primary Completion
September 15, 2023
Study Completion
December 14, 2024
Last Updated
May 19, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR
- Time Frame
- Data about Clinical Study Report will become available after all samples are obtained, analyzed and study completed. The data will be available for 12 months period.
- Access Criteria
- The IPD will be uploaded to the registration system, any investigator will be able to access IPD
It is planned to share individual participant data in terms of changes in microbiota composition of breast milk with different storage conditions. Special data about identity of participants will be kept blinded.